WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 82
GDP / capita (US$): 43'8241 Child (under 5 years) mortality rate: 102

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 1'332  1'318  1'293  1'252  1'192  668  496  360 
Births 20  20  20  20  19  15  14  12 
Surviving infants 20  20  20  19  19  14  14  11 
Pop. less than 5 years 103  98  94  90  88  72  66  50 
Pop. less than 15 years 280  272  262  249  247  206  162  124 
Female 15-49 years 304  303  300  294  281  162  113  75 

Number of reported case

(Click for retrospective incidence data for Bahrain)
Diphtheria
Japanese encephalitis
Measles 59  1'861 
Mumps 59  29  18  46  16  167 
Pertussis 106 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Bahrain)
Vaccine year result method % card seen                                                
BCG          100  87  73  81  80  63 
DTP1 1994  99     82  99  100  99  100  98  98 
DTP3 1994  90     82  99  99  100  100  98  97  94  92 
HepB_BD          99  100  100 
HepB3 1994  88     82  99  99  100  100  98  97 
Hib3          99  99  100  100  97  97 
JapEnc         
MCV 1994  94     82  100  100  100  100  100  98  87  63 
MCV2          100  100  96  98  100  92 
PCV1          100  100  100  100  99 
PCV3          100  99  100  100  96 
Pol3 1994  90     82  99  99  100  100  97  97  94  92 
Rota1          98  99  97  71  87 
Rota_last          97  96  96  59  81 
Rubella1          100  100 
TT2plus          38  36  40  59  27  71  41 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Bahrain)
DTP1 99  99  99  99  98  98  97  89 
DTP3 99  99  99  99  98  97  94  72 
HepB3 99  99  99  99  98  97 
HepB_BD
Hib3 99  99  99  99  97  97 
MCV 99  99  99  99  99  98  87  45 
MCV2 99  99  96  98  99  92 
PAB 94  94  94  94  94  84  48 
PCV3 99  99  99  99  96 
Pol3 99  99  99  99  97  97  94  72 
Rota_last 97  96  96  59  81 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes infants born to parents originally from TB endemic area
DT 2, 4, 6, 18 months; 5 years; Yes Childern with contraindications or allergic to Pertussis componant of the vaccine
DTaP 5 years; Yes Preschool vaccination
DTaPHibHepIPV 2 months; Yes
DTwPHibHepB 4, 6, 18 months; Yes
HIB > 5 years; Yes high risk groups
HepA 18 months; 2 years; Yes and Catch up Vaccination for 12&13 yrs , travellers and high risk groups
HepB Birth; 1 month; Yes Hep B for Newborns of HBsAg positive mothers or unknwon HBsAg status and adults at risk
IPV 2, 4, 6, 18 months; 5 years; Yes For immunocompromized and their household
Influenza Yes recommended from 6 month of age & above for High Risk Groups and offered to any one requesting the vaccine provided no contraindications
MMR 1, 5 years; Yes and risk groups
MenACWY 2 years; Yes Travellers to haj and certain countries & High risk groups including certain occupations at risks
OPV 4, 6, 18 months; 5 years; Yes
Pneumo_conj 2, 4, 6 months; 1 year; Yes as a single dose for those at 50 years of age and above
Pneumo_ps >=65 years; Yes high risk groups between age of 2- 64 years as a single dose and revaccination dose after 5 years for certain risk categories.
Rotavirus 2, 4 months; Yes
Td >10 years; Yes Pregnat women,Post trauma, certain occupations at risk &Haj pilgrams, others at risk of exposure
Tdap 13 years; Yes School students Vaccination, elderly and other at risk.
Typhoid Yes Travellers, certain occupations at risk & High risk groups
Varicella Yes High risk groups and their household, Health care workers
YF Yes Travellers

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2015  2012-2015      2006-2012     
Nº of districts with microplans that include activities to raise immunization coverage number      

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number  
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100    100 
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100% 100  100  100  100    100   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100  100  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.